It was reported that the procedure was performed to treat a lesion in the left anterior descending artery (lad).An unspecified xience skypoint stent was implanted successfully.After the procedure, when the patient went to the recovery room, the patient experienced dyspnea.An acute thrombosis was observed, the patient was treated with thrombolytics and aspiration was performed with a catheter.The patient became stable and was discharged.
|
The device was not returned for evaluation.A review of the lot history record and complaint history of the reported lot could not be conducted because the part and lot numbers were not provided.A conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.The reported patient effects of dyspnea and thrombosis are listed in the xience skypoint, everolimus eluting coronary stent system (eecss), electronic instructions for use as known patient effects of coronary stenting procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|